Skip to content
  • Saturday, 30 May 2026
  • 10:59 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • OrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 Dominance
Laboratory Automation & Robotics

OrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 Dominance

Lana Keisha Apr 14, 2026 0

OrsoBio, a specialized biotechnology firm dedicated to pioneering therapies for obesity and its associated metabolic conditions, is strategically charting a…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders

Lana Keisha Apr 3, 2026 0

OrsoBio, a specialized biotechnology company strategically focused on addressing obesity and its myriad related metabolic dysfunctions, is charting a course…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders

Lana Keisha Mar 26, 2026 0

OrsoBio, a specialized biotechnology firm dedicated to pioneering treatments for obesity and its associated metabolic disorders, is strategically charting a…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders and pioneering a new frontier in obesity therapeutics

Lana Keisha Mar 19, 2026 0

OrsoBio, a dynamic biotech enterprise dedicated to advancing novel therapies for obesity and a spectrum of obesity-related metabolic disorders, is…

Read More
Innovative Glycan-Based IVF Technology Enhances Sperm Viability and Fertilization Efficiency at the University of IllinoisThe Hidden Skill Gap: Why SQL and Python Are No Longer Enough for Data ProfessionalsUnlocking Superior Fruit Quality: "Housekeeping" Gene Discovery Promises Enhanced Nutrition and Flavor Without Sacrificing Plant GrowthRegeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace MedicineProtecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma InnovationStudy Links Vitamin B12 and Folate Deficiencies to Chronic Fatigue and Reduced Motivation in Healthy AdultsEnvironmental Control of Superconductivity in Twisted Bilayer Graphene Opens New Frontiers for Quantum Electronics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace Medicine
Dwi Wanna May 30, 2026
Laboratory Automation & Robotics
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
Lana Keisha May 30, 2026
Neuroscience & Brain Research
Study Links Vitamin B12 and Folate Deficiencies to Chronic Fatigue and Reduced Motivation in Healthy Adults
Rifan Muazin May 30, 2026
Advanced Materials Science
Environmental Control of Superconductivity in Twisted Bilayer Graphene Opens New Frontiers for Quantum Electronics
Nila Kartika Wati May 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ